In 2023, EU exports of medicinal and pharmaceutical products to countries outside the EU went down by -3.5% when compared with 2022. On the other hand, EU imports increased by 6.1% in 2023. In 2023, exports reached €277 billion, while imports stood at €119 billion. Consequently, the EU's trade surplus in medicinal and pharmaceutical products amounted to €158 billion, marking the second-highest figure ever recorded, following the peak in 2022 at €174 billion. In 2023, Germany was the EU’s largest extra-EU exporter (€62 billion), followed by Belgium (€44 billion) and Ireland (€37 billion), all three registering decreases when compared with 2022. The largest extra-EU importers of medicinal and pharmaceutical products were Belgium (€26 billion), followed by Germany (€20 billion) and the Netherlands (€16 billion). The main destination of extra-EU exports of medicinal and pharmaceutical products in 2023 was the United States, accounting for a third (33.2%; €92 billion) of these exports, followed by Switzerland (15.5%; €43 billion) and China (7.7%; €21 billion). Imports of these products to the EU came mainly from the United States, accounting for 39.5% of all EU imports of these products, then Switzerland (32.3%) and the United Kingdom (6.9%). Eurostat data show that, in 2023, Romania exported 327 million euros worth of drugs and pharmaceutical products outside the EU, while imports amounted to 659 million euros. In terms of weight, Romania's exports represented only 1.3% of the total exports of the EU block of medicines and pharmaceutical products, while imports stood at 17.9% of the EU's total imports, the highest level.